BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Favalli EG, Maioli G, Biggioggero M, Caporali R. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic. Expert Rev Clin Immunol 2021;17:561-71. [PMID: 33787418 DOI: 10.1080/1744666X.2021.1908887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Q, Wang D, Lin R, Lv Q, Wang W. IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. Front Immunol 2022;13:1013322. [DOI: 10.3389/fimmu.2022.1013322] [Reference Citation Analysis]
2 Dewanjee S, Kandimalla R, Kalra RS, Valupadas C, Vallamkondu J, Kolli V, Dey Ray S, Reddy AP, Reddy PH. COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges. Cells 2021;10:3291. [PMID: 34943795 DOI: 10.3390/cells10123291] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Radu AF, Bungau SG. Management of Rheumatoid Arthritis: An Overview. Cells 2021;10:2857. [PMID: 34831081 DOI: 10.3390/cells10112857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
4 Marcacci G, Fiorentino G, Volzone F, Falcone U, Parrella R, Donnarumma D, D'Ovidio S, Annunziata A, Micallo G, Portella G, De Chiara A, De Filippi R, Crisci S, Pinto A. Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab. Infect Agent Cancer 2021;16:38. [PMID: 34078415 DOI: 10.1186/s13027-021-00376-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]